| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes.
|
J Abnorm Psychol
|
2012
|
2.86
|
|
2
|
The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K-SADS-PL-K).
|
Yonsei Med J
|
2004
|
2.26
|
|
3
|
A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
|
Pediatrics
|
2008
|
2.22
|
|
4
|
A randomized, controlled trial of integrated home-school behavioral treatment for ADHD, predominantly inattentive type.
|
J Am Acad Child Adolesc Psychiatry
|
2007
|
1.73
|
|
5
|
Waxing and waning in concert: dynamic comorbidity of conduct disorder with other disruptive and emotional problems over 7 years among clinic-referred boys.
|
J Abnorm Psychol
|
2002
|
1.52
|
|
6
|
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
|
Arch Pediatr Adolesc Med
|
2006
|
1.26
|
|
7
|
Family correlates of oppositional and conduct disorders in children with attention deficit/hyperactivity disorder.
|
J Abnorm Child Psychol
|
2005
|
1.22
|
|
8
|
Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.
|
J Child Adolesc Psychopharmacol
|
2013
|
1.19
|
|
9
|
ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.
|
J Am Acad Child Adolesc Psychiatry
|
2003
|
1.09
|
|
10
|
ADHD subtype differences in motivational responsivity but not inhibitory control: evidence from a reward-based variation of the stop signal paradigm.
|
J Clin Child Adolesc Psychol
|
2007
|
1.08
|
|
11
|
A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder.
|
J Dev Behav Pediatr
|
2010
|
1.07
|
|
12
|
Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD.
|
CNS Spectr
|
2008
|
1.07
|
|
13
|
Validity of the sluggish cognitive tempo, inattention, and hyperactivity symptom dimensions: neuropsychological and psychosocial correlates.
|
J Abnorm Child Psychol
|
2012
|
0.97
|
|
14
|
Can executive functions explain the relationship between Attention Deficit Hyperactivity Disorder and social adjustment?
|
J Abnorm Child Psychol
|
2009
|
0.97
|
|
15
|
Validity of the sluggish cognitive tempo symptom dimension in children: sluggish cognitive tempo and ADHD-inattention as distinct symptom dimensions.
|
J Abnorm Child Psychol
|
2014
|
0.96
|
|
16
|
Social skills differences among attention-deficit/hyperactivity disorder types in a chat room assessment task.
|
J Abnorm Child Psychol
|
2007
|
0.95
|
|
17
|
ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study.
|
J Am Acad Child Adolesc Psychiatry
|
2005
|
0.92
|
|
18
|
Sluggish cognitive tempo in abnormal child psychology: an historical overview and introduction to the special section.
|
J Abnorm Child Psychol
|
2014
|
0.92
|
|
19
|
Educational outcomes of a collaborative school-home behavioral intervention for ADHD.
|
Sch Psychol Q
|
2013
|
0.89
|
|
20
|
Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.
|
J Child Adolesc Psychopharmacol
|
2006
|
0.88
|
|
21
|
Child ADHD severity and positive and negative parenting as predictors of child social functioning: evaluation of three theoretical models.
|
J Atten Disord
|
2010
|
0.87
|
|
22
|
Family correlates of comorbid anxiety disorders in children with attention deficit/hyperactivity disorder.
|
J Abnorm Child Psychol
|
2006
|
0.82
|
|
23
|
Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
|
J Child Adolesc Psychopharmacol
|
2007
|
0.80
|
|
24
|
Additive effects of parent adherence on social and behavioral outcomes of a collaborative school-home behavioral intervention for ADHD.
|
Child Psychiatry Hum Dev
|
2014
|
0.80
|
|
25
|
Bifactor latent structure of ADHD/ODD symptoms: predictions of dual-pathway/trait-impulsivity etiological models of ADHD.
|
J Child Psychol Psychiatry
|
2014
|
0.79
|
|
26
|
Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents.
|
Clin Ther
|
2013
|
0.78
|
|
27
|
Prevention of serious conduct problems in youth with attention deficit/hyperactivity disorder.
|
Expert Rev Neurother
|
2012
|
0.77
|
|
28
|
Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
|
J Child Adolesc Psychopharmacol
|
2014
|
0.77
|
|
29
|
Negative social preference in relation to internalizing symptoms among children with ADHD predominantly inattentive type: girls fare worse than boys.
|
J Clin Child Adolesc Psychol
|
2013
|
0.77
|
|
30
|
New directions for therapeutics in ADHD.
|
Neurotherapeutics
|
2012
|
0.75
|
|
31
|
Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13 Month Follow-up.
|
J Am Acad Child Adolesc Psychiatry
|
2020
|
0.75
|